Vlerick expertise in Healthcare Management

1. European emergency health fund is needed to limit the impact of future crises

   The unprecedented public health crisis caused by COVID-19 overstretched the structures and mechanisms of the European Union, in particular those that deal with emergencies. There is a need for deeper union and collaboration across the European health care sector, as well as a need for a significant financial cushion for rapid and predictably increasing funding. In their new policy paper, Professor David Veredas, Professor Simon Ashby and doctoral researcher Dimitrios Kolokas propose the creation of an Emergency Health Financing Facility (EHFF), which would limit the impact of a future crisis on the EU and its member States.

2. How to determine the hospital treatment costs for breast cancer patients?

   Healthcare costs are on the rise globally. And factors such as the increase in aging population, advancement in medical technology, and the current reimbursement system contribute to this rise. In addition, we see a lack of cost transparency and understanding centred around costs. A new study by doctoral researcher Erin Roman, Professor Brecht Cardoen and Professor Filip Roodhooft analyses the variability in treatment costs for breast cancer, using several patient and disease related factors, to better understand cost drivers.